Live Breaking News & Updates on ஐபோன் சிகிச்சை

Stay updated with breaking news from ஐபோன் சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Magic mushrooms- Plant offers treatment in psychiatric illness


July 27, 2021
The Inaugural staging of CanEx Psychedelics Summit was hosted at the Jewel Grande Montego Bay Resort in Montego Bay, St. James, Jamaica from July 15-16.
Trinidadian-born Douglas Gordon, Founder of CanEx Jamaica and CEO of Silo Wellness – a vertical Mushroom company that grows its mushroom in Jamaica – said that he felt it necessary for the discussion surrounding the emerging industry needed to start in Jamaica.
Jamaica is one of the few places where producing magic mushrooms is still legal and is also one of two locations – the other being Oregon- where Silo Wellness hosts its mushroom retreats.
Psychedelics are a class of hallucinogenic substances that produce changes in perception, mood, and cognitive processes of which include magic mushrooms otherwise known as Psilocybin Mushrooms. Researchers say extracts from mushrooms have a strong track record in treating psychiatric and psychosomatic illnesses. ....

University Of The West Indies , Saint Andrew , Saboto Caesar , Levaughn Flynn , Douglas Gordon , Jewel Grande Montego , Faculty Of Medical Sciences , First International Treatment Centre For Psychedelic Psychiatry , Cannabis Licensing Authority , Plant Quarantine Division , Canex Psychedelics Summit , Jewel Grande Montego Bay Resort , Montego Bay , Canex Jamaica , Silo Wellness , Floyd Green , Magic Mushrooms , Grenadines Minister , Rural Transformation , Winston De La Haye , Medical Director , Aion Therapeutic , First International Treatment Centre , Psychedelic Psychiatry , Deputy Dean , Medical Sciences ,

Investegate |Apollon Formularies Announcements | Apollon Formularies: Apollon Formulations Kill Prostate Cancer Cells


 
Apollon Formularies Plc (AQSE: APOL) ( Apollon  
or the  Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange is pleased to announce that its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing. ¹ This finding is in addition to the results recently announced on May 18, 2021² that Apollon formulations were successful in killing HER2+ breast cancer cells, and the announcement on June 28, 2021³ that Apollon formulations were successful in killing triple-negative breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ),a BC based international pharmaceutical company trading on the Canadian Securities Exchange.  ....

United Kingdom , United States , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Apollon Formularies Plc , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , Peterhouse Capital , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Apollon Jamaica Research Development , Formularies Plc , Aion Therapeutic ,